Anti-Mitochondrial Antibody (AMA) Test – Detailed Guide

The Anti-Mitochondrial Antibody (AMA) Test detects autoantibodies against mitochondria, which are strongly associated with Primary Biliary Cholangitis (PBC), a chronic autoimmune liver disease that leads to bile duct damage and liver dysfunction.

---

Why is the Anti-Mitochondrial Antibody (AMA) Test Done?

✅ To Diagnose Primary Biliary Cholangitis (PBC)

• AMA is present in ~95% of PBC cases
• Helps distinguish PBC from other liver diseases

✅ To Investigate Unexplained Liver Dysfunction

• Used in cases of elevated liver enzymes (especially ALP & GGT)
• Helps identify autoimmune causes of liver disease

✅ To Monitor Disease Progression & Treatment Response

• AMA levels remain detectable throughout the disease
• Helps evaluate response to Ursodeoxycholic Acid (UDCA) therapy

---

Test Procedure

🩸 Blood Sample Collection:

• A blood sample is drawn from a vein
• No fasting required
• Results available in 3–7 days

---

Normal Range & Interpretation

🔹 AMA is highly specific for PBC (~95%), but a small number of cases may be AMA-negative.
🔹 A positive AMA test should be followed by liver function tests and imaging.

---

What Do Abnormal AMA Levels Mean?

🔴 Positive AMA Suggests:

• Primary Biliary Cholangitis (PBC) (Most Common Cause)
• Autoimmune Hepatitis-PBC Overlap Syndrome
• Other Autoimmune Liver Diseases (Rare)

🟢 Negative AMA:

• PBC is unlikely, but further testing may be needed if symptoms persist
• Liver biopsy may still be required in AMA-negative cases

---

Next Steps If AMA Is Positive?

🔬 Additional Liver Function & Autoimmune Tests:

• Liver Enzymes (ALP, GGT, ALT, AST, Bilirubin) – Elevated in liver disease
• Total & Direct Bilirubin – Assesses bile flow obstruction
• Antinuclear Antibody (ANA) & Smooth Muscle Antibody (SMA) – Helps differentiate from Autoimmune Hepatitis
• IgM Levels – Elevated in PBC
• Liver Ultrasound, MRCP (Magnetic Resonance Cholangiopancreatography) – To rule out bile duct obstructions

✅ Treatment for PBC:

• Ursodeoxycholic Acid (UDCA) – First-line therapy to slow disease progression
• Obeticholic Acid (OCA) – Used for patients unresponsive to UDCA
• Liver Transplant (in end-stage liver disease cases)

---

Key Takeaways

🔹 AMA is highly specific for PBC (~95% of cases).
🔹 A positive AMA test warrants further liver function testing.
🔹 Early treatment with UDCA can slow disease progression.
🔹 Liver transplant may be needed in severe cases.